Effect of scavenger receptor class B type I antagonist ITX5061 in patients with hepatitis C virus infection undergoing liver transplantation.
Rowe IA, Tully DC, Armstrong MJ, Parker R, Guo K, Barton D, Morse GD, Venuto CS, Ogilvie CB, Hedegaard DL, McKelvy JF, Wong-Staal F, Allen TM, Balfe P, McKeating JA, Mutimer DJ.
Rowe IA, et al. Among authors: parker r.
Liver Transpl. 2016 Mar;22(3):287-97. doi: 10.1002/lt.24349.
Liver Transpl. 2016.
PMID: 26437376
Free PMC article.
Clinical Trial.